Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Aortic stenosis is the most common adult heart valve condition seen in the Western world and its incidence continues to rise. No established disease modifying treatments retard progression of the stenotic process. Recent insights into the pathogenesis of calcific aortic stenosis suggest that the disease mimics atherosclerosis. The natural history and progression of calcific aortic stenosis are described with particular emphasis on new and emerging medical treatments that may modify the disease process. In particular, statins and angiotensin converting enzyme inhibitors appear to hold promise but definitive evidence from large clinical trials is awaited.

Original publication

DOI

10.1136/hrt.2005.066852

Type

Journal article

Journal

Heart

Publication Date

06/2006

Volume

92

Pages

729 - 734

Keywords

Angiotensin-Converting Enzyme Inhibitors, Aortic Valve Stenosis, Calcinosis, Drug Therapy, Combination, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors